{
  "patent_number": "US 11499167",
  "country": "US",
  "title": "Engineering Cells to Make Gene Therapy Viruses Using AAVrh.10",
  "original_title": "Method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby",
  "summary": "This patent describes specific engineered cells that contain parts of the AAVrh.10 virus and an additional non-viral genetic sequence, designed to produce gene therapy vectors.",
  "what_it_does": "The patent claims a \"cultured host cell\" that has been genetically modified. This cell contains a \"recombinant nucleic acid molecule\" (an engineered piece of DNA) that carries instructions for two main things: first, making specific parts of the AAVrh.10 virus, such as its \"vp1 capsid protein\" (amino acids 1 to 738 of SEQ ID NO: 81), or vp2, or vp3, or specific nucleotide sequences (like 845 to 3058 of SEQ ID NO: 59); and second, a \"heterologous non-AAV sequence.\" This \"heterologous\" part is the therapeutic genetic material that a gene therapy aims to deliver. For example, a cell could be engineered to produce the outer shell of the AAVrh.10 virus, while also carrying the gene for a missing protein in a patient. Some claims also specify the presence of a \"functional rep gene\" (which helps the virus replicate) and that the recombinant molecule can be a \"plasmid\" (a common way to introduce DNA into cells).",
  "what_it_does_not_cover": [
    "Does not cover AAVrh.10 sequences or proteins existing outside of a cultured host cell.",
    "Does not cover host cells containing AAVrh.10 components without an additional \"heterologous non-AAV sequence.\"",
    "Does not cover other types of adeno-associated viruses (AAVs) beyond the specific AAVrh.10 variant described.",
    "Does not cover gene therapy vectors that use entirely different viral or non-viral delivery systems.",
    "Does not cover cells containing only the AAV 'rep gene' without the specified capsid protein or nucleotide sequences."
  ],
  "filed": "2021-10-12",
  "granted": "2022-11-15",
  "expires": "2041-10-12",
  "status": "active",
  "holder": "University of Pennsylvania",
  "holder_url": "https://patentbrief.org/company/university-of-pennsylvania",
  "inventors": [
    {
      "name": "James M. Wilson",
      "url": "https://patentbrief.org/inventor/james-m-wilson"
    },
    {
      "name": "Mauricio R. Alvira",
      "url": "https://patentbrief.org/inventor/mauricio-r-alvira"
    },
    {
      "name": "Guangping Gao",
      "url": "https://patentbrief.org/inventor/guangping-gao"
    }
  ],
  "times_cited": 0,
  "tags": [
    "biotech",
    "pharmaceutical",
    "gene_editing"
  ],
  "abstract": "Adeno-associated virus rh.10 sequences, vectors containing same, and methods of use are provided.",
  "url": "https://patentbrief.org/patent/us/11499167/method-of-detecting-andor-identifying-adeno-associated-virus-aav-sequences-and-i",
  "markdown_url": "https://patentbrief.org/patent/us/11499167/method-of-detecting-andor-identifying-adeno-associated-virus-aav-sequences-and-i/md",
  "google_patents_url": "https://patents.google.com/patent/US11499167",
  "relatedPatents": [
    {
      "patentNumber": "11357868",
      "countryCode": "US",
      "title": "New Adeno-Associated Virus Capsids for Gene Therapy",
      "url": "https://patentbrief.org/patent/us/11357868/adeno-associated-virus-aav-clades-sequences-vectors-containing-same-and-uses-the"
    },
    {
      "patentNumber": "12735721",
      "countryCode": "US",
      "title": "Engineered AAV Vectors for Targeted Gene Delivery to Specific Body Parts",
      "url": "https://patentbrief.org/patent/us/12735721/engineered-adeno-associated-aav-vectors-for-transgene-expression"
    },
    {
      "patentNumber": "12735723",
      "countryCode": "US",
      "title": "Treating Muscular Dystrophy with a Self-Complementary AAV Gene Therapy",
      "url": "https://patentbrief.org/patent/us/12735723/self-complementary-adeno-associated-virus-vector-and-its-use-in-treatment-of"
    },
    {
      "patentNumber": "4703008",
      "countryCode": "US",
      "title": "How to Make Human Erythropoietin (EPO) Using Engineered DNA",
      "url": "https://patentbrief.org/patent/us/4703008/neupogen-g-csf-filgrastim"
    },
    {
      "patentNumber": "11661612",
      "countryCode": "US",
      "title": "How Engineered TALE Proteins Can Edit Genes",
      "url": "https://patentbrief.org/patent/us/11661612/dna-binding-proteins-and-uses-thereof"
    }
  ]
}